These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 23415907

  • 1. Reduced hepatotoxicity by total glucosides of paeony in combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Chen Z, Li XP, Li ZJ, Xu L, Li XM.
    Int Immunopharmacol; 2013 Mar; 15(3):474-7. PubMed ID: 23415907
    [Abstract] [Full Text] [Related]

  • 2. Total glucosides of paeony can reduce the hepatotoxicity caused by Methotrexate and Leflunomide combination treatment of active rheumatoid arthritis.
    Xiang N, Li XM, Zhang MJ, Zhao DB, Zhu P, Zuo XX, Yang M, Su Y, Li ZG, Chen Z, Li XP.
    Int Immunopharmacol; 2015 Sep; 28(1):802-7. PubMed ID: 26292180
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of total glucosides of paeony combined with methotrexate and leflunomide for active rheumatoid arthritis: a meta-analysis.
    Huang Y, Wang H, Chen Z, Wang Y, Qin K, Huang Y, Ba X, Lin W, Tu S.
    Drug Des Devel Ther; 2019 Sep; 13():1969-1984. PubMed ID: 31354242
    [Abstract] [Full Text] [Related]

  • 4. Clinical safety of total glucosides of paeony adjuvant therapy for rheumatoid arthritis treatment: a systematic review and meta-analysis.
    Liu B, Meng X, Ma Y, Li H, Liu Y, Shi N, Chen Y, Wang Y, Lu C.
    BMC Complement Med Ther; 2021 Mar 26; 21(1):102. PubMed ID: 33771151
    [Abstract] [Full Text] [Related]

  • 5. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep 26; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 6. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
    Curtis JR, Beukelman T, Onofrei A, Cassell S, Greenberg JD, Kavanaugh A, Reed G, Strand V, Kremer JM.
    Ann Rheum Dis; 2010 Jan 26; 69(1):43-7. PubMed ID: 19147616
    [Abstract] [Full Text] [Related]

  • 7. [Comparative study on clinical efficacy of using methotrexate singly or combined with total glucosides of Paeony in treating rheumatoid arthritis].
    Du JH, Dong BD.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jun 26; 25(6):540-2. PubMed ID: 16025972
    [Abstract] [Full Text] [Related]

  • 8. Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate.
    Alves JA, Fialho SC, Morato EF, Castro GR, Zimmermann AF, Ribeiro GG, Neves FS, Pereira IA.
    Rev Bras Reumatol; 2011 Jun 26; 51(2):141-4. PubMed ID: 21584420
    [Abstract] [Full Text] [Related]

  • 9. [Clinical observation on effect of total glucosides of paeony combined with methotrexate on rheumatoid arthritis].
    Wang Y, Xing HY.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Sep 26; 27(9):839-40. PubMed ID: 17969901
    [Abstract] [Full Text] [Related]

  • 10. Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
    Narváez J, Díaz-Torné C, Ruiz JM, Hernández MV, Torrente-Segarra V, Ros S, Rodriguez de la Serna A, Díaz-López C, Sanmartí R, Nolla JM.
    Semin Arthritis Rheum; 2011 Dec 26; 41(3):401-5. PubMed ID: 21862107
    [Abstract] [Full Text] [Related]

  • 11. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
    Kremer J, Genovese M, Cannon GW, Caldwell J, Cush J, Furst DE, Luggen M, Keystone E, Bathon J, Kavanaugh A, Ruderman E, Coleman P, Curtis D, Kopp E, Kantor S, Weisman M, Waltuck J, Lindsley HB, Markenson J, Crawford B, Fernando I, Simpson K, Strand V.
    J Rheumatol; 2004 Aug 26; 31(8):1521-31. PubMed ID: 15290730
    [Abstract] [Full Text] [Related]

  • 12. Effects of total glucosides from paeony (Paeonia lactiflora Pall) roots on experimental atherosclerosis in rats.
    Li J, Chen CX, Shen YH.
    J Ethnopharmacol; 2011 May 17; 135(2):469-75. PubMed ID: 21453765
    [Abstract] [Full Text] [Related]

  • 13. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.
    Arthritis Rheum; 2004 Feb 17; 50(2):364-71. PubMed ID: 14872477
    [Abstract] [Full Text] [Related]

  • 14. A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis.
    Feng ZT, Xu J, He GC, Cai SJ, Li J, Mei ZG.
    Clin Rheumatol; 2018 Jan 17; 37(1):35-42. PubMed ID: 28748514
    [Abstract] [Full Text] [Related]

  • 15. [Clinical observation on effects of leflunomid and total glucosides of paeony on rheumatoid arthritis].
    Zhao YX, Liu Y.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Apr 17; 26(4):355-7. PubMed ID: 16689008
    [Abstract] [Full Text] [Related]

  • 16. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
    Bird P, Griffiths H, Tymms K, Nicholls D, Roberts L, Arnold M, Burnet S, de Jager J, Scott J, Zochling J, Littlejohn G.
    J Rheumatol; 2013 Mar 17; 40(3):228-35. PubMed ID: 23322457
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.
    Weinblatt ME, Kremer JM, Coblyn JS, Maier AL, Helfgott SM, Morrell M, Byrne VM, Kaymakcian MV, Strand V.
    Arthritis Rheum; 1999 Jul 17; 42(7):1322-8. PubMed ID: 10403258
    [Abstract] [Full Text] [Related]

  • 18. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C, Chen S, Gu Y, Lao Z, Ni L, Yu Q, Xu J, Li X, Liu J, Sun L, He P, Ma J, Xu S, Ding C.
    Chin Med J (Engl); 2003 Aug 17; 116(8):1228-34. PubMed ID: 12935395
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritis.
    Benucci M, Saviola G, Baiardi P, Manfredi M, Sarzi-Puttini P, Atzeni F.
    Int J Immunopathol Pharmacol; 2011 Aug 17; 24(1):269-74. PubMed ID: 21496415
    [Abstract] [Full Text] [Related]

  • 20. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D, Park GS, Paulus HE, Simpson KM, Elashoff D, Cohen SB, Emery P, Dorrier C, Furst DE.
    Arthritis Rheum; 2005 Oct 17; 52(10):3030-8. PubMed ID: 16200612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.